Search

Latest Developments in Neuromyelitis Optica Spectrum Disorder: Diagnostics, Treatments and Patient-Centred Care

Released On: July 7, 2023 Valid for Credit Through: July 6, 2024 Target Audience  This activity has been designed to meet the educational needs of neurologists, including neuroimmunologists; neuroradiologists; ophthalmologists, including neuro-ophthalmologists; and specialist neurology nurses involved in the management of NMOSD. Overview In this touchSATELLITE SYMPOSIUM activity, leading experts in neuromyelitis optica spectrum disorder …

Targeting Pathways of Disease Progression in Early Multiple Sclerosis

Released On: June 30, 2023 Valid for Credit Through: June 30, 2024 Credits Available for Physicians: Maximum of 1.50 AMA PRA Category 1 Credit(s)™ Target Audience and Goal Statement Neurologists, neuroscientists, nurse practitioners, neuroscience nurses and other healthcare professionals involved in the clinical study, management, and care of patients with multiple sclerosis. This CME activity will …

Deciphering Neuromyelitis Optica Spectrum Disorder: Addressing Real Clinician Questions Concerning Diagnosis and Management

Course opens: June 20, 2023Course expires: June 20, 2024 Overview Though neuromyelitis optica spectrum disorder (NMOSD) has had a specific lab marker (AQP4 antibody) for many years, its relapsing nature and overlapping syndromes still cause it to be confused with multiple conditions such as multiple sclerosis (MS), leading to inappropriate and even harmful treatment. The …

Contemporary Considerations in Multiple Sclerosis Treatment: A Post-Pandemic Educational Curriculum MedPoints™ in Multiple Sclerosis

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC) and Catamount Medical Education. This activity is supported by independent educational grants fromBiogen and Bristol Myers Squibb. Target Audience MS specialists, general neurologists, nursing professionals, pharmacists, PAs, and patient advocates in the care of people living with multiple sclerosis (MS). Faculty Robert …

Building Clinical Confidence: Evidence-based Care for People Living with MS

This activity is jointly provided by The Consortium of Multiple Sclerosis Centers (CMSC)and Catamount Medical Education. This activity is supported by independent educational grants from Janssen Scientific Affairs, LLC and Sanofi. Target Audience Neurologists, primary care physicians, nurse practitioners, nurses, physician associates (PAs), rehabilitation specialists, mental health specialists, radiologists, and other clinicians who are part …

Collaborating Across the Continuum™: Managing Relapsing MS – A Focus on the Utility of CD20-Targeted B-Cell Therapy

Release Date: November 30, 2022 Expiration Date: November 30, 2023 Faculty: Stephen Krieger, MD, FAAN Jacci Bainbridge, PharmD, FCCP Denise Bruen, ANP-BC, MSN, MSCN Activity Overview Following the success of anti-CD20 antibodies in the treatment of multiple sclerosis (MS), there has been a shift in understanding of its pathophysiology. B cells have been identified as …